Connect Biopharma Total Other Income Expense Net Over Time
| CNTB Stock | USD 1.00 0.01 0.99% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Connect Biopharma Performance and Connect Biopharma Correlation. Connect |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Connect Biopharma. If investors know Connect will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Connect Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.39) | Revenue Per Share 0.438 | Return On Assets (0.12) | Return On Equity (0.18) |
The market value of Connect Biopharma is measured differently than its book value, which is the value of Connect that is recorded on the company's balance sheet. Investors also form their own opinion of Connect Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Connect Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Connect Biopharma's market value can be influenced by many factors that don't directly affect Connect Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Connect Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Connect Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Connect Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Other Income Expense Net Analysis
Compare Connect Biopharma and related stocks such as Assembly Biosciences, Neoleukin Therapeutics, and Instil Bio Total Other Income Expense Net Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASMB | (10.5 T) | (302.3 K) | 65.1 K | 201 K | 167.7 K | (27 K) | (1.1 M) | (615.1 K) | 3.1 M | 4.3 M | 2.6 M | 302 K | 1 M | 3.5 M | 3.6 M |
| TIL | 63 K | 63 K | 63 K | 63 K | 63 K | 63 K | 63 K | 63 K | 63 K | 63 K | (3.9 M) | (1.2 M) | 1.2 M | 3.1 M | 3.2 M |
| CTMX | 71 K | 71 K | 71 K | 71 K | (55 K) | (1.7 M) | (69 K) | (27 K) | (68 K) | 8.2 M | 1.8 M | 172 K | 2 M | 9.8 M | 10.3 M |
| ACHL | (215 K) | (215 K) | (215 K) | (215 K) | (215 K) | (215 K) | (215 K) | (215 K) | (215 K) | (215 K) | 531 K | 3.1 M | 7.3 M | 6.1 M | 3.7 M |
| NXTC | 80 K | 80 K | 80 K | 80 K | 80 K | 80 K | 80 K | 80 K | 397 K | 3.7 M | 4.6 M | 1.4 M | 1.2 M | 4.9 M | 2.6 M |
| NUVB | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | 1.9 M | 6.5 M | 15.5 M | 24 M | 25.2 M |
| OVID | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 30.3 K | 120.3 K | 201.5 K | 951.7 K | 948.2 K | 395.4 K | (45.7 K) | 1.4 M | 6.9 M | 7.3 M |
Connect Biopharma and related stocks such as Assembly Biosciences, Neoleukin Therapeutics, and Instil Bio Total Other Income Expense Net description
My Equities
My Current Equities and Potential Positions
| Connect Biopharma Holdings | CNTB |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | China |
| Exchange | NASDAQ Exchange |
USD 1.0
Check out Connect Biopharma Performance and Connect Biopharma Correlation. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Connect Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.